I have read queries on this forum of those of us who have experienced vision problems attributable to statin use; myself included. It is not your imagination.
*www.ncbi.nlm.nih.gov/pubmed/18930555
Abstract: Casey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, Oregon 97239-4197, USA. *eyedrug@ohsu.edu
PURPOSE: To report the association between 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase inhibitors (statins) and diplopia, blepharoptosis (ptosis), and ophthalmoplegia. DESIGN: Database study. PARTICIPANTS: Two hundred fifty-six subjects studied. CONCLUSIONS: According to WHO criteria, the relationship between statin therapy and diplopia, ptosis, or ophthalmoplegia is possible.
Your ophthalmologist may be interested in this document.
Best,
Brooks